Clinical Trial Results: A Study of TAK-341 in Treatment of Multiple System Atrophy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for TAK-341 in treating Multiple System Atrophy have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• TAK-341

Snippet

Sponsor: Takeda | Conditions: Multiple System Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2026-06-02